106
Views
19
CrossRef citations to date
0
Altmetric
Review

Dendritic cell vaccine strategies for renal cell carcinoma

Pages 221-232 | Published online: 24 Jan 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

H Eichler, Xd Nguyen, D Roelen, Cm Celluzzi, D McKenna, D Pamphilon, A Blair, Ej Read, Ta Takahashi & Zm Szczepiorkowski. (2008) Multicenter study on in vitro characterization of dendritic cells. Cytotherapy 10:1, pages 21-29.
Read now

Articles from other publishers (18)

Robert O. Dillman & Carol Depriest. (2018) Dendritic Cell Vaccines Presenting Autologous Tumor Antigens from Self-renewing Cancer Cells in Metastatic Renal Cell Carcinoma. Journal of Exploratory Research in Pharmacology 3:4, pages 93-101.
Crossref
Iwona Hus, Magdalena Wasiak, Justyna Miłczek & Jacek Roliński. (2012) Generacja komórek dendrytycznych z monocytów krwi obwodowej chorych na przewlekłą białaczkę limfocytową przy użyciu GM-CSF, IL-4 i TNF nie indukuje ich właściwości tolerogennych. Acta Haematologica Polonica 43:2, pages 215-221.
Crossref
Shin-ichi Koizumi, Kazutaka Masuko, Daiko Wakita, Sachi Tanaka, Rieko Mitamura, Yoshihiro Kato, Homare Tabata, Masahiro Nakahara, Hidemitsu Kitamura & Takashi Nishimura. (2012) Extracts of Larix Leptolepis effectively augments the generation of tumor antigen-specific cytotoxic T lymphocytes via activation of dendritic cells in TLR-2 and TLR-4-dependent manner. Cellular Immunology 276:1-2, pages 153-161.
Crossref
Bernhard Frankenberger & Dolores J. Schendel. (2012) Third generation dendritic cell vaccines for tumor immunotherapy. European Journal of Cell Biology 91:1, pages 53-58.
Crossref
Juliane S Stickel, Natalie Stickel, Jörg Hennenlotter, Karin Klingel, Arnulf Stenzl, Hans-Georg Rammensee & Stefan Stevanović. (2011) Quantification of HLA class I molecules on renal cell carcinoma using Edman degradation. BMC Urology 11:1.
Crossref
Yeranddy A. Alpizar, Benjamin Chain, Mary K. Collins, John Greenwood, David Katz, Hans J. Stauss & N. Avrion Mitchison. (2011) Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies. Cancer Immunology, Immunotherapy 60:8, pages 1127-1135.
Crossref
Peter Middel, Sven Brauneck, Werner Meyer & Heinz-Joachim Radzun. (2010) Chemokine-mediated distribution of dendritic cell subsets in renal cell carcinoma. BMC Cancer 10:1.
Crossref
Alexander BuchnerHeike PohlaGerald WillimskyBernhard FrankenbergerRonald FrankAndrea Baur-MelnykMichael SiebelsChristian G. StiefAlfons HofstetterJoachim KoppAntonio PezzuttoThomas BlankensteinRalph ObernederDolores J. Schendel. (2010) Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients with Metastatic Renal Cell Carcinoma. Human Gene Therapy 21:3, pages 285-297.
Crossref
Claudia Papewalis, Margret Ehlers & Matthias Schott. (2010) Advances in Cellular Therapy for the Treatment of Thyroid Cancer. Journal of Oncology 2010, pages 1-11.
Crossref
Christiane Geiger, Elfriede Nößner, Bernhard Frankenberger, Christine S. Falk, Heike Pohla & Dolores J. Schendel. (2009) Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma. Journal of Molecular Medicine 87:6, pages 595-612.
Crossref
Thomas SimonJean-François FonteneauMarc Grégoire. (2009) Dendritic cell preparation for immunotherapeutic interventions. Immunotherapy 1:2, pages 289-302.
Crossref
S Elena Gimenez, Ciprian Secasan & Jay D Raman. (2009) Prognostic markers and targeted therapies for renal cell carcinoma. Future Oncology 5:2, pages 197-205.
Crossref
Chuanhai Cao, Xiaoyang Lin, Chi Zhang, Monika M. Wahi, Inge Wefes, Gary Arendash & Huntington Potter. (2008) Mutant Amyloid-beta-sensitized dendritic cells as Alzheimer's disease vaccine. Journal of Neuroimmunology 200:1-2, pages 1-10.
Crossref
Anita Schmitt, Li Li, Krzysztof Giannopoulos, Jochen Greiner, Peter Reinhardt, Markus Wiesneth & Michael Schmitt. (2008) Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia. Transfusion 48:5, pages 861-870.
Crossref
Maarten F Corsten & Khalid Shah. (2008) Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare. The Lancet Oncology 9:4, pages 376-384.
Crossref
Miran Javorovic, Susanne Wilde, Anke Zobywalski, Elfriede Noessner, Volker Lennerz, Thomas Wölfel & Dolores J. Schendel. (2008) Inhibitory Effect of RNA Pool Complexity on Stimulatory Capacity of RNA-pulsed Dendritic Cells. Journal of Immunotherapy 31:1, pages 52-62.
Crossref
Robert J. Amato. (2007) Current Immunotherapeutic Strategies in Renal Cell Carcinoma. Surgical Oncology Clinics of North America 16:4, pages 975-986.
Crossref
Bernhard Frankenberger, Elfriede Noessner & Dolores J. Schendel. (2007) Immune suppression in renal cell carcinoma. Seminars in Cancer Biology 17:4, pages 330-343.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.